Fig. 3
From: Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation
Treatment with MSC-derived NV resulted in decreased airway inflammation in BAL fluid and lung tissue compared to EV treatment. A, B The total number of inflammatory cells (A) and eosinophils (B) in BAL fluid. C, D The number of T cells (C) and eosinophils (D) that infiltrated into the lung tissues. E, F The level of Eotaxin-2 in BAL fluid (E) and lung tissues (F). Data are presented as the mean ± SEM. *P < 0.05, **P < 0.01 by one-way ANOVA with Tukey’s post test (n = 5)